Anesthesiology and Pulmonary Medicine
Subscribe to Anesthesiology and Pulmonary Medicine
View Sample

FREE Email Newsletter

Teleflex Finalizes Supplier Agreement with Healthscope Group of Hospitals

April 18, 2013 7:00 am | by The Associated Press | News | Comments

LIMERICK, Pa.--(BUSINESS WIRE)--Apr 18, 2013--Teleflex Incorporated (NYSE: TFX), a leading global provider of medical devices for critical care and surgery, has, through its wholly owned Australian subsidiary LMA PacMed Pty Ltd, finalized a supplier agreement with the Healthscope Group of...

Teleflex Signs New Agreement with HealthTrust for Anesthesia Products

April 15, 2013 7:00 am | by The Associated Press | News | Comments

LIMERICK, Pa.--(BUSINESS WIRE)--Apr 15, 2013--Teleflex Incorporated (NYSE: TFX), a leading global provider of medical devices for critical care and surgery, has announced that it has been awarded a new agreement for its line of regional anesthesia products with HealthTrust, a healthcare group purchasing organization.

Icy Therapy Spot Treats Cancer in the Lung

April 14, 2013 10:00 am | by PR Newswire | News | Comments

Frozen balls of ice can safely kill cancerous tumors that have spread to the lungs, according to the first prospective multicenter trial of cryoablation. The results are being presented at the Society of Interventional Radiology's 38th Annual Scientific Meeting in New Orleans.


Teleflex Receives FDA 510(k) Clearance for the ISO-Gard® Mask with ClearAir™ Technology

April 11, 2013 5:00 pm | by The Associated Press | News | Comments

LIMERICK, Pa.--(BUSINESS WIRE)--Apr 11, 2013--Teleflex Incorporated (NYSE:TFX), a leading global provider of medical devices for critical care and surgery, has announced that its Anesthesia and Respiratory business unit received 510(k) clearance 1 for the ISO-Gard ® Mask with ClearAir™ Technology,...

AsthmaSense Cloud Launches With New Features To Better Monitor Asthma

April 11, 2013 3:28 pm | by PR Newswire | News | Comments

SEVERNA PARK, Md., April 11, 2013 /PRNewswire/ -- Medical technology company, iSonea Ltd. (ASX: ISN; OTCQX: ISOAY), launched Thursday the newest smartphone asthma management application, AsthmaSense™ Cloud, to help asthmatics adhere to physician-prescribed treatment...

Sleep Nation, Inc. Wins All 100 Medicare Competitive Bid Areas

April 11, 2013 2:00 pm | by PR Newswire | News | Comments

NASHVILLE, Tenn., April 11, 2013 /PRNewswire/ -- Sleep Nation, Inc., a national provider of CPAP supplies, today announced a major accomplishment as it has signed contracts with the Centers for Medicare & Medicaid Services (CMS)  to be reimbursed for all competitive bid...

BD Announces FDA 510(k) Clearance and Commercial Launch of BD UltraSafe PLUS Passive Needle Guard

April 11, 2013 1:57 pm | by BD Medical | News | Comments

BD Medical, a segment of BD, a leading global medical technology company, announced today the commercial launch of a new passive needle guard technology, BD UltraSafe PLUS™. The BD UltraSafe PLUS™ Passive Needle Guard has received 510(k) clearance as an anti-needlestick safety device.

FDA Clears Medtronic's Affinity Fusion Blood Oxygenation System

April 2, 2013 2:49 pm | by Mass Device | News | Comments

Medtronic said the FDA granted 510(k) clearance for its Affinity Fusion blood oxygenator, used during open heart surgery to replace the function of the lungs. The Minneapolis-area medical device company, which is the world's largest pure-play medtech maker, said the Affinity Fusion is designed to filter a patient's blood to remove particles and air during oxygenation.


ResMed Takes Aim at APEX Medical over Respiratory Device Patents

March 29, 2013 2:36 pm | by Mass Device | News | Comments

San Diego medical devices maker ResMed announced this week that it's going to "take action" to protect its respiratory patents, most recently by filing an infringement lawsuit against APEX Medical. ResMed filed parallel actions with the the International Trade Commission and in U.S federal courts, alleging that a handful of APEX's products violate patents for respiratory devices and masks.

Recall: Spacelabs Healthcare Pulls Anesthesia Workstations over Excess CO2 Risk

March 27, 2013 4:33 pm | by Mass Device | News | Comments

Washington-based Spacelabs Healthcare recalled a slate of its Spacelabs BleaseSirius and BleaseFocus anesthesia workstations as well as certain absorbers contained in service kits over concerns that they may contain a defect which could result in excess carbon dioxide in the gas delivered to a patient. The FDA slapped the recall with Class I status...

Class I Medical Device Recall: Spacelabs Medical, Inc., Spacelabs Anesthesia Workstations and Service Kits

March 26, 2013 12:00 am | by U.S. Food & Drug Administration | News | Comments

These products are used in the hospital environment and in locations not requiring mobility of the products. They provide respiratory support to deliver oxygen, air, and nitrous oxide in a controlled manner to various patient-breathing circuits with or without the use of a mechanical ventilator, and may be used to deliver anesthetic vapor.

COWIN Helps Sensaris Certify the ZAO Biomedical Sensor

March 25, 2013 10:13 am | by COWIN | News | Comments

Sensaris has announced that it has developed a novel, multi-sensor device for monitoring vital signs. Called the ZAO, it is currently going through the certification process and will be available mid 2013. Roughly the same size as a thick paperback book, it is designed to provide professional level diagnostic data so that it can be used by medical professionals and yet its low target volume price point of around €550 means that it can also be used by the home health market.

Leading U.S. Pulmonologists to Investigate Impact of Mauna Kea Technologies' Cellvizio on Lung Cancer Diagnosis

March 21, 2013 12:45 pm | by The Associated Press | News | Comments

Mauna Kea Technologies (NYSE Euronext: MKEA), leader in the optical biopsy market and developer of Cellvizio®, the fastest way to see cancer, announced today that it has launched a registry study to determine the impact of Cellvizio optical biopsies on the diagnosis of lung cancer, the leading cause of cancer death in the world.


"Miracle" Medical Device Saves Teen from Lifetime on Ventilator

March 20, 2013 11:45 am | by PR Newswire | News | Comments

FORT LAUDERDALE, Fla., March 20, 2013 /PRNewswire/ -- In January, 18 year old Reggie Lamour's neck was broken while he played in a rugby game in Naples, Florida. In one moment, the active, athletic young adult with a bright future faced a life-time of ventilator dependency. But there...

Wearable Artificial Lung to Be Developed at Pitt Through $3.4 Million Grant

March 19, 2013 11:50 am | by University of Pittsburgh | News | Comments

Each year, nearly 350,000 Americans die of some form of lung disease, with another 150,000 patients needing short- and long-term care. Unfortunately, current breathing-support technologies are cumbersome, often requiring patients to be bedridden and sedated.

Premier Healthcare Alliance Doles Out Four New Contracts

February 27, 2013 3:09 pm | by Mass Device | News | Comments

Group purchasing organization Premier Healthcare Alliance awarded 4 new contracts for regional anesthesia, surgical instruments, operating room lights and brooms and instrument containers to a bevy of medical device companies. All of the new deals became available to acute care and continuum care Premier members Feb. 1.

ALung Technologies Receives CE Mark Approval for Hemolung Respiratory Assist System

February 25, 2013 3:00 pm | by The Associated Press | News | Comments

PITTSBURGH--(BUSINESS WIRE)--Feb 25, 2013--ALung Technologies, Inc., a leading developer of innovative respiratory assist devices, announced today that it has received CE Mark approval for its Hemolung Respiratory Assist System (RAS). Receipt of the CE Mark allows the Hemolung RAS to be sold in...

Teleflex Launches The Invisible Risk Campaign to Educate PACU Clinicians About Waste Anesthetic Gas Exposure

February 20, 2013 7:00 am | by The Associated Press | News | Comments

LIMERICK, Pa.--(BUSINESS WIRE)--Feb 20, 2013--Teleflex Incorporated (NYSE:TFX), a corporate partner of the American Society of PeriAnesthesia Nurses (ASPAN) and the American Society of Anesthesiologists (ASA), has launched The Invisible Risk campaign. The campaign is designed to educate clinicians...

Sorin Group Announces the Acquisition of Alcard

February 19, 2013 3:30 am | by The Associated Press | News | Comments

MILAN--(BUSINESS WIRE)--Feb 19, 2013--Sorin Group (MIL:SRN) (Reuters Code: SORN.MI), a global medical device company and a leader in the treatment of cardiovascular diseases, announced today the acquisition of Alcard Industria Mecanica Ltda (“Alcard”), a Brazilian leading manufacturer of medical...

Class I Medical Device Recall: GE Healthcare, LLC, Giraffe and Panda T-Piece Resuscitation Systems, and the Giraffe and Panda Bag and Mask Resuscitation Systems

February 14, 2013 12:00 am | by U.S. Food & Drug Administration | News | Comments

The oxygen and air wall inlet fittings and/or labels on the back panel of the resuscitation systems may have been reversed during assembly. As a result, this could potentially reverse the air/oxygen concentrations; for example, a setting of 100% oxygen could have an output of 21% oxygen and vice versa. The settings of the blender knob would no longer be accurate.

Sorin Group Announces Preliminary Results for 2012

February 7, 2013 12:06 pm | by The Associated Press | News | Comments

MILAN--(BUSINESS WIRE)--Feb 7, 2013--At a meeting held today and chaired by Rosario Bifulco, the Sorin S.p.A. (MIL:SRN) Board of Directors analyzed the results for the fourth quarter 2012 and the preliminary unaudited consolidated results for the year of 2012. The final draft of the financial...

European patient registry in venous thromboembolism (VTE) enrols first patient

February 6, 2013 11:29 am | by PR Newswire | News | Comments

MUNICH, February 6, 2013 /PRNewswire/ -- The registry plans to gather data from more than 4,000 patients with VTE across seven European countries, providing insights into the clinical management of a disease that is a leading cause of morbidity and mortality[1] Daiichi Sankyo...

ERT, Johns Hopkins University and the University of Washington Expand Study on Effects of Home-Health Monitoring on Exacerbations of Cystic Fibrosis

February 4, 2013 9:52 am | News | Comments

ERT, a global technology-driven provider of health outcomes research services to biopharmaceutical organizations, medical device companies and contract research organizations (CROs), along with pulmonary researchers at the Johns Hopkins University School of Medicine  and University of Washington, today announced an expansion to the Early Intervention in Cystic Fibrosis Exacerbation (eICE) Study.

Covidien Supports Centers for Medicare & Medicaid Services Quality Measure #3040

January 21, 2013 9:24 am | by Covidien | News | Comments

Covidien (NYSE: COV), a leading global provider of healthcare products and recognized innovator in patient monitoring and respiratory care devices, today announces its support for the Centers of Medicare & Medicaid Services (CMS) proposed quality measure #3040, currently considered for a Medicare program rule. Quality measures help CMS assess performance of hospitals participating...

Dip Molded Products Play Critical Role in Medical Equipment Design

December 19, 2012 3:10 pm | by Ed Sullivan | Articles | Comments

Dip molding may not be a term that readily comes to mind when surgeons begin complicated procedures. Yet, without this sophisticated, highly controllable process, many medical devices used daily in hospitals could not meet stringent certification requirements.

You may login with either your assigned username or your e-mail address.
The password field is case sensitive.